Download PDF
Hamostaseologie 1984; 04(04): 111-117
DOI: 10.1055/s-0038-1659933
Originaler Artikel
Schattauer GmbH

Beteiligung der plasmatischen Gerinnung bei der Entstehung und Persistenz der Glomerulonephritis

A. Kanfer
1   Service de Néphrologie, Centre Hospitalier Universitaire Bichat, Paris, France
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Vassalli P, Simon G, Rouiller C. Electron microscopic study of glomerular lesions resulting from intravascular fibrin formation. Amer. J. Pathol. 43: 579-617 1963;
    PubMedGoogle Scholar
  • 2 Margaretten W, Csavossy I, McKay D.G. An electron microscopic study of thrombin-induced disseminated intravascular coagulation. Blood 29: 169-181 1967;
    PubMedGoogle Scholar
  • 3 McCluskey R.T, Vassalli P. Experimental glomerular diseases. In: Rouiller C, Muller A.F. (Eds.) The Kidney. Academic Press; New York: 1969: 83-198.
    CrossrefGoogle Scholar
  • 4 Sraer J.D, Delarue F, Dard S, De Seigneux R, Morel-Maroger L, Kanfer A. Glomerular fibrinolytic activity after thrombin perfusion in the rat. Lab. Invest. 32: 515-517 1975;
    PubMedGoogle Scholar
  • 5 Margaretten W, Zunker H.O, McKay D.G. Production of the generalized Shwartzman reaction in pregnant rats by intravenous infusion of thrombin. Lab. Invest. 13: 552-559 1964;
    PubMedGoogle Scholar
  • 6 Whitaker A.N. Acute renal failure in disseminated intravascular coagulation. Progr. Biochem. Pharmacol. 9: 45-64 1974;
    PubMedGoogle Scholar
  • 7 Humair L, Potter E.V, Kwaan H.C. The role of fibrinogen in renal disease. J. Clin. Lab. Med. 74: 60-71 1969;
    PubMedGoogle Scholar
  • 8 Robboy S.J, Major M.C, Colman R.W, Minna J.D. Pathology of disseminated intravascular coagulation (DIC). Human Path. 3: 327-343 1972;
    CrossrefPubMedGoogle Scholar
  • 9 Vassalli P, McCluskey R.T. The pathogenic role of the coagulation process in rabbit Masugi nephritis. Amer. J. Pathol. 45: 653-673 1964;
    PubMedGoogle Scholar
  • 10 Bone J.M, Valdes A.J, Germuth F.G, Lubowitz H. Heparin therapy in anti-basement membrane nephritis. Kidney International 5: 72-79 1975;
    PubMedGoogle Scholar
  • 11 Giroux L, Verroust P, Morel-Maroger L, Delarue F, Delauche M, Sraer J.D. Glomerular fibrinolytic activity during nephrotoxic nephritis. Lab. Invest. 40: 415-422 1979;
    PubMedGoogle Scholar
  • 12 Briggs J.D, Kwaan H.C, Potter E.V. The role of fibrinogen in renal disease. Fibrinolytic and anticoagulant treatment of nephrotoxic serum nephritis in mice. J. Lab. Clin. Med. 74: 715-724 1969;
    PubMedGoogle Scholar
  • 13 Lagrue G, Lèvent M, Gouault-Heil-mann M, Hirbec G, Branellec A. Étude de quelques paramètres de l’hémostase dans la néphrite de Masugi du lapin. Path. Biol. 23: 139-144 1975;
    PubMedGoogle Scholar
  • 14 Naish P, Penn G.B, Evans D.J, Peters D.K. The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin. Sci. 42: 643-646 1972;
    CrossrefPubMedGoogle Scholar
  • 15 Holdsworth S.R, Thomson N.M, Glasgow E.F, Atkins C. The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin. Exp. Immunol. 37: 38-43 1979;
    PubMedGoogle Scholar
  • 16 Borrero J, Todd M.E, Becker C.G, Becker E.L. Masugi nephritis: the renal lesion and the coagulation processes. Clin. Nephrol. 1: 86-93 1973;
    PubMedGoogle Scholar
  • 17 Border W.A, Wilson C.B, Dixon F.J. Failure of heparin to affect two types of experimental glomerulonephritis in rabbits. Kidney Int. 8: 140-148 1975;
    CrossrefPubMedGoogle Scholar
  • 18 Thomson N.M, Simpson I.J, Evans D.J, Peters D.K. Defibrination with ancrod in experimental chronic immune complex nephritis. Clin. Exp. Immunol. 20: 527-535 1975;
    PubMedGoogle Scholar
  • 19 Becker G.J, Hancock W.W, Stow J.L, Glasgow E.F, Atkins R.C, Thomson N.M. Involvement of the macrophage in experimental chronic immune complex glomerulonephritis. Nephron 32: 227-233 1982;
    CrossrefPubMedGoogle Scholar
  • 20 Wardle E.N. A study of intravascular coagulation in immune complex glomerulonephritis by use of 131I-labelled fibrinogen and 125I-labelled antigen. Clin. Sei. Mol. Med. 45: 35-50 1973;
    PubMedGoogle Scholar
  • 21 Baliah T, Drummond K.N. The effect of anticoagulation on serum sickness nephritis in rabbits. Proc. Soc. Exp. Biol. Med. 40: 329-335 1972;
    PubMedGoogle Scholar
  • 22 Naish P.F, Evans D.J, Peters D.K. The effects of defibrination with ancrod in experimental allergic glomerular injury. Clin. Exp. Immunol. 20: 303-309 1975;
    PubMedGoogle Scholar
  • 23 Wardle E.N. Intravascular coagulation in experimental acute renal failure. Throm-bos. Diathes. Haemorrh. 29: 579-591 1973;
    PubMedGoogle Scholar
  • 24 Lambert P.H, Salmon J. Reactions antigene-anticorps et coagulation intravasculai-re. Acta Allergol. 22: 209-219 1967;
    CrossrefPubMedGoogle Scholar
  • 25 Cochrane C.G, Koffler D. Immune complex disease in experimental animals and man. Advanc. Immunol. 16: 185-264 1973;
    PubMedGoogle Scholar
  • 26 McKay D.G, Philips L.L, Kaplan D.H, Henson J.B. Chronic intravascular coagulation in aleudan disease of mink. Amer. J. Pathol. 50: 899-911 1967;
    PubMedGoogle Scholar
  • 27 Michaud A, Sapin C, Leca G, Aiach M, Druet P. Involvement of hemostasis during an autoimmune glomerulonephritis induced by mercuric chloride in brown norway rats. Thrombos. Res. (In press.)
    PubMedGoogle Scholar
  • 28 Andrassy K, Ritz E, Mauerhoff T, Bommer J. What is the evidence for activated coagulation in glomerulonephritis?. Amer. J. Nephrol. 2: 293-300 1982;
    CrossrefPubMedGoogle Scholar
  • 29 Loschiavo C, Previato G, Valvo E, Lupo A, Tessitore N, Chiaramonte S, Maschio G. Clinical significance of urinary fibrinogen degradation products in renal disease. Nephron 28: 200-203 1981;
    CrossrefPubMedGoogle Scholar
  • 30 McLeish K.R, Yum M.N, Luft F.C. Rapidly progressive glomerulonephritis in adults: clinical and histologic correlations. Clin. Nephrol. 10: 43-50 1978;
    PubMedGoogle Scholar
  • 31 Sonsino E, Nabarra B, Kazatchkine M, Hinglais N, Kreis H. Les gloméruloné-phrites proliferatives extra-capillaires dites »glomerulonephrites malignes«. In: Actualités Néphrologiques de l’Hôpital Necker. Flammarion; Paris: 1972: 119-161.
    Google Scholar
  • 32 Lévy M, Broyer M, Arsan A, Lév-Bentolila D, Habib R. Glomérulonéphrites du purpura rhumatoide chez l’enfant. Histoire naturelle et étude immunopathologi-que. In: Actualités Néphrologiques de l’Hôpital Necker. Flammarion; Paris: 1976: 174-226.
    Google Scholar
  • 33 Whitworth J.A, Morel-Maroger L, Mignon F, Richet G. The significance of extracapillary proliferation. Nephron 16: 1-19 1976;
    CrossrefPubMedGoogle Scholar
  • 34 Kanfer A, Sraer J.D, Feintuch M.-J, Morel-Maroger L, Beaufils P.h, Richet G. Insuffisance rénale aigüe au cours de la périartérite noueuse. Nouv. Presse Med. 5: 1883-1888 1976;
    PubMedGoogle Scholar
  • 35 Beaufils M, Morel-Maroger L, Sraer J.D, Kanfer A, Kourilsky O, Richet G. Acute renal failure of glomerular origin during visceral abscesses. New Engl. J. Med. 295: 185-189 1976;
    CrossrefPubMedGoogle Scholar
  • 36 Druet P.h, Bariety J, Bernard D, Lagrue G. Les glomerulopathies primitives à dépôts mésangiaux d’IgA et d’IgG. Etude clinique et morphologique de 52 cas. Presse Med. 78: 583-587 1970;
    PubMedGoogle Scholar
  • 37 De Werra P, Morel-Maroger L, Leroux-Robert C, Richet G. Glomérulites à dépôts d’IgA diffus dans le mésangium. Etude de 96 cas chez l’adulte. Schweiz. Med. Wschr. 103: 761-768 1973;
    PubMedGoogle Scholar
  • 38 Kobayashi Y, Tateno S, Hiki Y, Shigematsu H. Ig A nephropathy: prognostic significance of proteinuria and histological alterations. Nephron 34: 146-153 1983;
    CrossrefPubMedGoogle Scholar
  • 39 Duffy J.L, Cinque T, Grishman E, Churg J. Intraglomerular fibrin, platelet aggregation, and subendothelial deposits in lipoid nephrosis. J. Clin. Invest. 49: 251-258 1970;
    CrossrefPubMedGoogle Scholar
  • 40 Morel-Maroger L, Verroust P, Méry J.P.h. Contribution of immunofluorescence to the diagnosis of glomerular diseases. In: Kluthe R, Vogt A, Batsford S.R. (Eds.) Glomerulonephritis. Thieme; Stuttgart: 1976. S.109-117.
    Google Scholar
  • 41 Saint-Hillier Y, Morel-Maroger L, Woodrow D, Richet G. Hyalinose segmentai-re et focale du floculus. Actualités Néphrologiques de l’Hôpital Necker. Flammarion, Paris 1975, p. 241-278.
    PubMedGoogle Scholar
  • 42 Chavaz A, Mignon F, Morel-Maroger L, Richet G. Glomérulites extramembraneuses. A propos de 92 observations. Schweiz. Med. Wschr. 107: 899-907 1977;
    PubMedGoogle Scholar
  • 43 Ferrano F, Kourilsky O, Morel-Maroger L. Acute endocapillary glomerulonephritis in adults: a histologic and clinical comparison between patients with and without initial acute renal failure. Clin. Nephrol. 19: 17-23 1983;
    PubMedGoogle Scholar
  • 44 Habib R, Kleinknecht C, Gubler M, Levy M. Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin. Nephrol. 1: 194-214 1973;
    PubMedGoogle Scholar
  • 45 Hinglais N, Garcia-Torres R, Kleinknecht D. Long-term prognosis in acute glomerulonephritis. The predictive value of early clinical and pathologic features observed in 65 patients. Amer. J. Med. 56: 52-60 1974;
    CrossrefPubMedGoogle Scholar
  • 46 Hedner U. Urinary fibrin/fibrinogen derivatives. Thrombos. Diathes. Haemorrh. 34: 693-708 1975;
    PubMedGoogle Scholar
  • 47 Ekberg M, Pandolfi M. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis. Brit. Med. J. 2: 17-19 1975;
    CrossrefPubMedGoogle Scholar
  • 48 Hedner U, Nilsson I.M. Maladies du rein et produits de dégradation de la fibrine (PDF). Actualités Néphrologiques de l’hôpital Necker. Flammarion, Paris 1973, p. 257-285.
    PubMedGoogle Scholar
  • 48a Chirawong P, Nanra R.S, Kincaid-Smith P. Fibrin degradation products and the role of coagulation in “persistent” glomerulonephritis. Ann. Intern. Med. 74: 853-859 1971;
    CrossrefPubMedGoogle Scholar
  • 49 Kamitsuji H, Kusumoto K, Taira K, Iida Y, Nakajima M, Fukui H. Localization of intrarenal cross-linked fibrin in children with various renal diseases. Nephron 35: 94-99 1983;
    CrossrefPubMedGoogle Scholar
  • 50 Donati M.B, Molla A, Michielsen P, Vermylen J. Measurement of urinary fibrino-gen-related material: méthodologie aspects. J. Lab. Clin. Med. 83: 921-936 1974;
    PubMedGoogle Scholar
  • 51 Hall C.L, Blainey J.D, Gaffney P.J. Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease. Nephron 23: 6-9 1979;
    CrossrefPubMedGoogle Scholar
  • 52 George C.R.P, Slichter S.J, Quadracci L.J, Striker G.Z, Harker L.A. A kinetic evaluation of hemostasis in renal disease. New Engl. J. Med. 291: 1111-1115 1974;
    CrossrefPubMedGoogle Scholar
  • 53 Wardle E.N. Fibrinogen catabolism studies in patients with renal disease. Quart. J. Med. 42: 205-219 1973;
    PubMedGoogle Scholar
  • 54 Alkjaersig N.K, Fletcher A.P, Lewis M.L, Cole B.R, Ingelfinger J.R, Robson A.M. Pathophysiological response of the blood coagulation system in acute glomerulonephritis. Kidney Int. 10: 319-328 1976;
    CrossrefPubMedGoogle Scholar
  • 55 Conté J, Boneu B, Mignon-Conté M, Sue J.M. Exploration of intraglomerular phenomena. In: Kincaid-Smith P, Mathew T.H, Becker E.L. (Eds.) Glomerulonephritis. Wiley; New York: 1973
    Google Scholar
  • 56 Hoyer J.R, Michael A.F, Hoyer L.W. Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases. J. Clin. Invest. 53: 1375-1384 1974;
    CrossrefPubMedGoogle Scholar
  • 57 Scheinman J.I. Immunochemical and biochemical studies of human glomerular cells in culture. In: Cummings N.B, Michael A.F, Wilson C.B. Immune Mechanisms in Renal Disease. Plenum Medical Book Comp.; New York: 1983
    Google Scholar
  • 58 Ekberg M, Nilsson I.M. Factor VIII and glomerulonephritis. Lancet I: 1111-1113 1975;
    PubMedGoogle Scholar
  • 59 Adhikari M, Coovadia H.M, Creig H.B.W, Christensen S. Factor VIII procoagulant activity in children with nephrotic syndrome and poststreptococcal glomerulonephritis. Nephron 22: 301-305 1978;
    CrossrefPubMedGoogle Scholar
  • 60 Salem H.H, Whitworth J.A, Koutts J, Kincaid-Smith P, Firkin B.G. Hypercoa-gulation in glomerulonephritis. Brit. Med. J. 282: 2083-2085 1981;
    CrossrefPubMedGoogle Scholar
  • 61 Kanfer A, Kleinknecht D, Broyer M, Josso F. Coagulation studies in 45 cases of nephrotic syndrome without uremia. Thrombos. Diathes. Haemorrh. 24: 562-571 1970;
    PubMedGoogle Scholar
  • 62 Heaf J.G, Jorgensen J, Nielsen L.P. Treatment and prognosis of extracapillary glomerulonephritis. Nephron 35: 217-224 1983;
    CrossrefPubMedGoogle Scholar
  • 63 Kincaid-Smith P, Saker B.M, Fairley K.F. Anticoagulants in “irreversible” acute renal failure. Lancet II: 1360-1363 1968;
    PubMedGoogle Scholar
  • 64 Meyrier A, Devergie A, Leroux-Robert C, Sraer J.D, Richet G. Nephropathies glomérulaires traitées par les anticoagulants. Evolution particulière en immunofluorescence suivie par biopsies rénales itératives. J. Urol. Nephrol. (Paris) 78: 738-740 1972;
    PubMedGoogle Scholar
  • 65 Brown C.B, Wilson D, Turner D, Cameron J.S, Ogg C.S, Chantier C, Gill D. Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet II: 1166-1172 1974;
    PubMedGoogle Scholar
  • 66 Pollak V.E, Glueck H.I, Weiss M.A, Lebron-Berges A, Miller M.A. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation. Amer. J. Nephrol. 2: 195-207 1982;
    CrossrefPubMedGoogle Scholar
  • 67 Maxwell D.R, Ozana T, Nielsen R.L, Luft F.C. Spontaneous recovery from rapidly progressive glomerulonephritis. Brit. Med. J. 2: 643 1979;
    CrossrefPubMedGoogle Scholar
  • 68 Lockwood C.M, Pearson T.A, Rees A.J, Evans D.J, Peters D.K. Immunosuppression and plasma-exchange in the treatment of Goodpasture’s syndrome. Lancet I: 711-715 1976;
    PubMedGoogle Scholar
  • 69 Swainson C.P, Robson J.S, Urbaniak S.J, Keller A.J, Kay A.B. Treatment of Goodpasture’s disease by plasma exchange and immunosuppression. Clin. Exp. Immunol. 32: 233-242 1978;
    PubMedGoogle Scholar
  • 70 Mueller-Eckhardt C.h, Luscher E.F. Immune reactions of human blood platelets. A comparative study on the effects on platelets of heterologous antiplatelet antiserum, antigen-antibody complexes, aggregated gammaglobulin and thrombin. Thrombos. Diathes. Haemorrh. 20: 155-167 1968;
    PubMedGoogle Scholar
  • 71 Horowitz H.J, Desprez R.M, Hook E.W. Effects of bacterial endotoxin on rabbit platelets. Enhancement of platelet factor 3 activity in vitro and in vivo. J. Exp. Med. 116: 619-633 1962;
    CrossrefPubMedGoogle Scholar
  • 72 Kaplan A.P, Gigli I, Austen K.F. Immunologic activation of Hageman factor and its relationship to fibrinolysis, bradyki-nin generation and complement. J. Clin. Invest. 50: 51a 1971;
    PubMedGoogle Scholar
  • 73 Shigematsu H. Glomerular events during the initial phase of rat Masugi nephritis. Virchows Arch. Abt. B. Zellpath. 5: 187-200 1970;
    PubMedGoogle Scholar
  • 74 Shigematsu H, Kobayashi Y, Tateno S, Hiki Y, Kuwao S. Ultrastructural glomerular loop abnormalities in IgA nephritis. Nephron 30: 1-7 1982;
    CrossrefPubMedGoogle Scholar
  • 75 Kondo Y, Shigematsu H, Kobayashi Y. Cellular aspects of rabbit Masugi nephritis. Lab. Invest. 27: 620-631 1972;
    PubMedGoogle Scholar
  • 76 Poskitt T.R. Immunologic and electron microscopic studies in Goodpasture’s syndrome. Amer. J. Med. 49: 250-257 1969;
    PubMedGoogle Scholar
  • 77 Griffin J.H, Cochrane C.G. Recent advances in the understanding of contact activation reactions. Semin. Thrombos. Haemost. 5: 254-273 1979;
    PubMedGoogle Scholar
  • 78 Glas P, Astrup T. Thromboplastin and plasminogen activator in tissues of the rabbit. Amer. J. Physiol. 219: 1140-1146 1970;
    PubMedGoogle Scholar
  • 79 Zeldis S.M, Nemerson Y, Pitlick F.A. Tissue factor (Thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies. Science 175: 766-768 1972;
    CrossrefPubMedGoogle Scholar
  • 80 Béguin S, Goutner A, Josso F. Tissue factor activity of rabbit peritoneal macrophages: influence of immune stimulation. Ann. Immunol. 128c: 785-798 1977;
    PubMedGoogle Scholar
  • 81 Rothberger H, Zimmerman T.S, Vaughan J.H. Leucocyte procoagulant activity. Enhancement of production in vitro by IgG and antigen-antibody complexes. J. Clin. Invest. 59: 549-557 1977;
    CrossrefPubMedGoogle Scholar
  • 82 Cattell V, Jamieson S.W. The origin of glomerular crescents in experimental nephrotoxic serum nephritis in the rabbit. Lab. Invest. 39: 584-590 1978;
    PubMedGoogle Scholar
  • 83 Thomson N.M, Holdsworth S.R, Glasgow E.F, Atkins R.C. The macrophages in the development of experimental crescentic glomerulonephritis. Amer. J. Pathol. 94: 223-235 1979;
    PubMedGoogle Scholar
  • 84 Atkins R.C, Glasgow E.F, Holds-worth S.R, Matthews F.E. The macrophage in human rapidly progressive glomerulonephritis. Lancet I: 830-832 1976;
    PubMedGoogle Scholar
  • 85 Harry T, Bryant D, Coles G.A, Davies M, Forit W. The detection of monocytes in human renal biopsies: a prospective study. Clin. Nephrol. 18: 29-33 1982;
    PubMedGoogle Scholar
  • 86 Magil A.B, Wadsworth L.D. Monocyte involvement in glomerular crescents. A histochemical and ultrastructural study. Lab. Invest. 47: 160-166 1982;
    PubMedGoogle Scholar
  • 87 Sarao E.N, Alvarenga F.B.F, Ruzany F, Gattass C.R. Distribution of mononuclear phagocytes in glomerulonephritis with crescents. Nephron 32: 265 1982;
    CrossrefPubMedGoogle Scholar
  • 88 Sindrey M, Marshall T.L, Naish P. Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis. Clin. Exp. Immunol. 36: 90-96 1979;
    PubMedGoogle Scholar
  • 89 Halpern B, Lagrue G, Fray A, Morard J.C, Militez P. Sur le traitement des nephropathies expérimentales par l’héparine. Perspectives d’application clinique. Presse Med. 73: 57-61 1965;
    PubMedGoogle Scholar
  • 90 Van Ginkel C.J.W, Van Aken W.G, Oh J.I.H, Vreeken J. Stimulation of monocyte procoagulant activity by adherence to different surfaces. Brit. J. Hematol. 37: 35-45 1977;
    CrossrefPubMedGoogle Scholar
  • 91 Shelley W.B, Juhlin L. Induction of fibrin thrombi by monocytes. Nature 270: 343-344 1977;
    CrossrefPubMedGoogle Scholar
  • 92 Hogg N. Human monocytes have prothrombin cleaving activity. Clin. Exp. Immunol. 53: 725-730 1983;
    PubMedGoogle Scholar
  • 93 Bergstein J.M, Michael A.F. Cortical fibrinolytic activity in normal and diseased human kidneys. J. Lab. Clin. Med. 70: 701-709 1972;
    PubMedGoogle Scholar
  • 94 Neugarten J, Feiner H.D, Schacht R.G, Gallo G.R, Baldwin D.S. Aggravation of experimental glomerulonephritis by superimposed clip hypertension. Kidney Int. 22: 257-263 1982;
    CrossrefPubMedGoogle Scholar
  • 95 Okoda S, Onoyama K, Fujimi S, Oh Y, Nomoto K, Omae T. Influence of hypertension on the progression of experimental autologous immune complex nephritis. J. Lab. Clin. Med. 101: 461-471 1983;
    PubMedGoogle Scholar